Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cordyceps bassiana fermentation product is a nutraceutical and traditional medicine developed by BioAsia Pharmaceutical. It is derived from the entomopathogenic fungus *Beauveria bassiana* (formerly *Cordyceps bassiana*) through a specialized solid-state fermentation process. BioAsia utilizes its culture collection of cordycipitoid fungi to produce these supplements, which are marketed for their potential health benefits in line with traditional Chinese medicine practices. The product is categorized as a health food or traditional medicine rather than a conventional pharmaceutical drug, and it lacks specific clinical trial data or defined molecular targets in Western pharmacological terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cordyceps bassiana fermentation product.